Tenosynovial Giant Cell Tumor, Diffuse Type

Tenosynovial Giant Cell Tumor, Diffuse Type — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01207492	Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor	completed	Phase 2	17	Andrew J. Wagner, MD, PhDOTHER	1	Feb 20, 2026	clinicaltrials
NCT05349643	A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT	completed	Phase 2	20	AmMax Bio, Inc.INDUSTRY	3	Jul 5, 2024	clinicaltrials
NCT04731675	An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee	completed	Phase 2	11	AmMax Bio, Inc.INDUSTRY	4	Jun 27, 2024	clinicaltrials
NCT04952896	Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease

Data updated 23 days agoSource updated Feb 20, 2026source: clinicaltrials